[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337217-105":59,"doc-detail-337217-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","usp20-mediates-malignant-phenotypic-changes-in-bladder-cancer-through-direct-interactions-with-yap1","USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1","","USP20 functions as a deubiquitinase that drives malignant phenotypic changes in bladder cancer by directly regulating YAP1. The Hippo-YAP1 axis is suppressed in bladder cancer, and pathway control involves coordinated ubiquitination and deubiquitination. Using siRNA screening and deubiquitinase overexpression, USP20 was identified as a YAP1 pathway-related DUB. USP20 increased YAP1 expression and stability by blocking K48-linked poly-ubiquitination and upregulating YAP1 downstream genes. Tissue microarray data linked elevated USP20 with YAP1 in tumor tissues.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/usp20-mediates-malignant-phenotypic-changes-in-bladder-cancer-through-direct-interactions-with-yap1/337217/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/usp20-mediates-malignant-phenotypic-changes-in-bladder-cancer-through-direct-interactions-with-yap1/337217.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is YAP1 regulation important in bladder cancer?","Question",{"text":113,"@type":114},"The Hippo-YAP1 pathway is a major driver of bladder cancer progression. YAP1 activity influences transcription of target genes that support malignant phenotypes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was USP20 identified as relevant to the Hippo/YAP1 pathway?",{"text":118,"@type":114},"The study used combined siRNA screening and deubiquitinase overexpression assays to identify USP20 as a Hippo/YAP1 pathway-related deubiquitinase.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism does USP20 use to affect YAP1?",{"text":122,"@type":114},"USP20 directly interacts with YAP1 and promotes its stability by inhibiting K48-linked poly-ubiquitination.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337217,1790181485,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Neoplasia 60 (2025) 101102  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1 |  |  | |\n| --- | --- | --- | --- |\n| Wensun Chena,1,2,* , Siqi Wu a,1, Yifan Chena,1 , Weijian Lia, Yiqing Cao b, Yingchun Lianga, Xiyu Daia, Xinan Chen a, Yilin Chen a, Tian Chena, Shenghua Liu a, Chen Yanga,1, Haowen Jiang a,*\u003Cbr>a Department of Urology, Huashan Hospital Fudan University Shanghai, PR China b Department of Pharmaceutical Analysis, Fudan University, Shanghai 201203, PR China |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords: Bladder cancer YAP1\u003Cbr>USP20\u003Cbr>Malignant phenotype deubiquitinase |  | Yes-associated protein 1 (YAP1) has attracted attention for its potential in the treatment of various types of malignancies. The Hippo-YAP1 axis is inhibited in bladder cancer (BC), which is a major driver of BC progression and oncogenesis. Hippo pathway activity is controlled by the phosphorylation cascade in the MST1/2-LATS1/2-YAP1 axis, in addition to other modifications such as ubiquitination of the Hippo pathway proteins through the co-regulation of E3 ligases and deubiquitinases. In this study, we identified USP20 as a Hippo/YAP1 pathwayrelated deubiquitinase using combined siRNA screening and a deubiquitinase overexpression assay. Further analysis revealed that USP20 directly regulated the expression of YAP1 and its downstream target genes connective tissue growth factor and cysteine-rich angiogenic inducer 61. A tissue microarray assay confirmed that USP20 expression was elevated in tumor tissues and correlated with YAP1 expression. Analysis of the underlying mechanisms revealed that USP20 directly interacted with the YAP1 protein and promoted its stability through inhibition of K48-linked poly-ubiquitination. Our findings revealed that USP20 serves as a deubiquitinase and regulates the Hippo-YAP1 pathway in BC. |  |\n\nIntroduction  \nBladder cancer (BC) is one of the most prevalent urinary cancers worldwide and caused over 200,000 deaths per year [1]. In China, BC has the highest mortality among urinary malignancies. Although a combination of surgery, chemotherapy, and targeted therapies has been used to treat BC, its prognosis remains unfavorable owing to the high risk of relapse and metastasis. The biomolecular landscape of BC has been unveiled over the past few decades, and several potential therapeutic targets have been discovered. However, the majority of these targets are not clinically druggable [2]. Thus, there is an urgent need to better understand the molecular mechanisms underlying BC progression to develop novel therapeutics for BC [3].  \nThe Hippo-YAP1 pathway is highly conserved among species and comprises a series of protein kinases. The regulatory protein Salvador family WW domain containing protein 1 (SAV1) activates macrophage stimulating 1/2 (MST1/2) through phosphorylation and activates and phosphorylates large tumor suppressors 1 and 2 (LATS1/2), which leads to the phosphorylation of YAP1/TAZ. Phosphorylated YAP1 is sequestered in the cytoplasm by directly binding to 14-3-3, which results in the degradation of YAP1 by the ubiquitin-proteasome process. The remaining YAP1 translocates to the nucleus and interacts with transcriptional enhanced associate domain (TEAD) to promote the transcription of YAP1 target genes that play important roles in the malignant phenotype of cancer cells [4].  \nHowever, the mechanisms underlying YAP1 regulation in BC remain  \nAbbreviations: BC, bladder cancer; CTGF, connective tissue growth factor; CYR61, cysteine-rich angiogenic inducer 61.  \n* Correspondence author at. Department of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.  \n[E-mail addresses:](E-mail addresses: wensunchen21@m.fudan.ed","cbCaibjlSrFZZSGT","https://ap.wps.com/l/cbCaibjlSrFZZSGT","pdf",16482970,"English","# Introduction\n## Background on bladder cancer and the need for molecular targets\n## Overview of the Hippo-YAP1 signaling axis\n## Rationale and study objectives\n# Results\n## Identification of USP20 as a Hippo/YAP1 pathway-related deubiquitinase\n## USP20 regulation of YAP1 and downstream target genes\n## USP20 expression in tumor tissues and correlation with YAP1\n## Mechanistic basis: direct interaction and K48-linked poly-ubiquitination","[{\"question\":\"Why is YAP1 regulation important in bladder cancer?\",\"answer\":\"The Hippo-YAP1 pathway is a major driver of bladder cancer progression. YAP1 activity influences transcription of target genes that support malignant phenotypes.\"},{\"question\":\"How was USP20 identified as relevant to the Hippo/YAP1 pathway?\",\"answer\":\"The study used combined siRNA screening and deubiquitinase overexpression assays to identify USP20 as a Hippo/YAP1 pathway-related deubiquitinase.\"},{\"question\":\"What mechanism does USP20 use to affect YAP1?\",\"answer\":\"USP20 directly interacts with YAP1 and promotes its stability by inhibiting K48-linked poly-ubiquitination.\"}]","USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1 | PDF",1790018189,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07950b4f4b0308f2f8f84ac5dec9ddf1.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d5dc8ab0f4f4b1977253e5a6af2e438.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07e4500d097209a9797edf389a1fcc93.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/641230df265c1a25e46059ae16ae10e1.webp",980,1306]